CLPT.US Clearpoint Neuro Inc

Healthcare Health Care Equipment & Supplies USA Stocks
8.48 USD
Close of Nov 14, 2026
8.27 19.63
Market cap
USD 272M
P/E
-
P/B
9.97x
ROE
-138.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CLPT.US undervalued?

Graham number

The Graham number of Clearpoint Neuro Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Clearpoint Neuro Inc fundamental analysis

No fundamental analysis for Clearpoint Neuro Inc yet.

Clearpoint Neuro Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Clearpoint Neuro Inc

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessori…

Full company profile